Journal of Virology, March 2001, p. 2475-2481, Vol. 75, No. 5
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.5.2475-2481.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Channing Laboratory, Harvard Medical School, Boston,1 and Center for Blood Research, Harvard University,2 and Harvard Microchemistry Facility,3 Cambridge, Massachusetts, and Institute of Medical Biochemistry, University of Oslo, Blindern, N-0317 Oslo, Norway4
Received 12 September 2000/Accepted 13 November 2000
EBNA-LP-associated proteins were identified by sequencing proteins
that immunoprecipitated with Flag epitope-tagged EBNA-LP (FLP) from
lymphoblasts in which FLP was stably expressed. The association of
EBNA-LP with Hsp70 (72/73) was confirmed, and sequences of DNA-PK
catalytic subunit (DNA-PKcs), HA95, Hsp27, prolyl 4-hydroxylase
-1
subunit,
-tubulin, and
-tubulin were identified. The fraction of
total cellular HA95 that associated with FLP was very high, while
progressively lower fractions of the total DNA-PKcs, Hsp70, Hsp 27,
-tubulin, and
-tubulin specifically associated with EBNA-LP as
determined by immunoblotting with antibodies to these proteins. EBNA-LP
bound to two domains in the DNA-PKcs C terminus and DNA-PKcs associated
with the EBNA-LP repeat domain. DNA-PKcs that was bound to EBNA-LP
phosphorylated p53 or EBNA-LP in vitro, and the phosphorylation of
EBNA-LP was inhibited by Wortmannin, a specific in vitro inhibitor of
DNA-PKcs.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|